- Case report
- Open Access
- Open Peer Review
Management of an extrasphincteric fistula in an HIV-positive patient by using fibrin glue: a case report with tips and tricks
© Papavramidis et al; licensee BioMed Central Ltd. 2010
- Received: 11 July 2009
- Accepted: 14 February 2010
- Published: 14 February 2010
Individuals with impaired immunity are at higher risk of perianal diseases. Concerning complex anal fistulas impaired healing and complication rates are also higher. Definitive treatment of a fistula aims controlling the purulent discharge and prevents its recurrence. It depends mainly on the trajectory of the fistula and the underlying disease.
We present a case of a HIV-positive patient with a complex extrasphincteric anal fistula who was treated successfully with fibrin glue application. We further, discuss tips and tricks when applying fibrin glue as plugging material in complex anal fistulas.
A sixty-one-year-old HIV-positive male referred to us for warts and extrasphincteric fistula. Because of the patients' immunological status, we opted against surgery and recommended fibrin glue plugging. The patient was discharged the same day. A follow-up examination was performed 5 days after the initial fibrin glue application showing that the fistula canal was obstructed. Three months and a year post-intervention the fistula tract remains closed.
The best treatment for a disease gives at least the same result with the other treatments with minimised risk for the life of the patient and minimal application effort. Conservative closure of fistula with fibrin plugging is simple, safe and with less morbidity than surgery. Our patient was successfully treated without endangering his life despite his precarious medical state. Not everybody believes in the effectiveness of fibrin glue application, however we consider this solution in cases of complex fistulas at least as primary procedure in special populations such as the immunosupressed.
- Fibrin Glue
- Fistula Tract
- Anal Incontinence
- Anal Fistula
- Complex Fistula
Individuals with diseases that reduce the body's immunity -such as AIDS or cancer- are at a higher risk of anal abscess and fistula formation . However, despite the higher incidence of fistula formation, no differences were observed concerning the healing time in simple fistulas . On the contrary, healing and complication rates were altered in complex fistulas .
In all individuals, definitive treatment of a fistula aims to control the purulent discharge and prevent its recurrence. Treatment depends mainly on the trajectory of the fistula and the underlying disease leading to the fistula formation [4, 5]. The standard treatments that can be used are various, mostly surgical in nature, including fistulotomy, excision of the external fistula tract, closure of the internal opening, curettage, endorectal advancement flap, a cutting seton or immediate reconstruction .
Fibrin glue pluging is a method explored in recent years in various types of fistulas with great success [7–9]. Recently, fibrin glue has been applied in perianal fistulas with diverse success rates [4, 5, 10].
We present a special case of a HIV-positive patient with a complex extrasphincteric anal fistula who was treated successfully with fibrin glue application. We further, discuss tips and tricks when applying fibrin glue as plugging material in fistulas.
Anal fistulas are divided into 4 categories, with the suprasphincteric category being the rarest and representing approximately 1% of the total number of fistulas. The present fistula additionally, enters in the category of "complex" fistulas after the definition given by Loungnarath et al . By this definition "complex" annals fistulas are those in which treatment by simple fistulotomy would result in significant impairment of continence. This category generally consists of high transsphincteric, suprasphincteric and extrasphincteric fistulas. The treatment of complex anal fistulas is one of the most challenging aspects of coloproctology and colorectal surgery.
The complexity of the present case is aggravated by the fact that the patient is HIV-positive. Approximately 30% of patients with HIV develop anorectal abscesses and fistulas . Anal fistulas in HIV-positive patients arise from the dentate line in similar locations to human immunodeficiency virus-negative patients . Anorectal procedures (for anal condylomata, fistula in ano, hemorrhoids, and perirectal abscess) are the most common operations performed in HIV-patients. No prospective data are available on operative morbidity and mortality in HIV-positive and HIV-negative patients. In retrospectives studies, investigators found a high incidence of serious wound complications after anorectal surgery and urged non-operative treatment for most anorectal diseases in HIV-infected patients [2, 3]. Although there is currently no scientific data on the prevalence of surgical complications among HIV patients compared to non-infected patients in colorectal surgery, it is more safely to avoid any type of major surgical treatment, as these patients have a weakened immune system. In this perspective, alternatives to conventional surgery were considered to the present patient.
Alternative to conventional surgery in complex anal fistulas are considered the use of fibrin glue (autologous or commercial) and the use of a biologic fistula plug (Surgisis®AFP™). Among those two choices we chose the first. Our choice was based on the fact that we had no experience with Surgisis and that all studies employing this material date less than 5 years, not permitting to evaluate the long-term results [13, 14]. On the other hand, fibrin glue application is a safe, cheap, reproducible, pain-free procedure, which eliminates the possibility of anal incontinence and can be performed under local anaesthesia . The fibrin glue application in the treatment of anal fistula is the guaranteed preservation of the sphincters, so it avoids the risk of incontinence, and creates minimal stress for the patient [4, 5, 10]. However, a final question arises -mainly theoretically- when coming to fibrin glue application: autologous or commercial? To our opinion commercial sealants have an advantage over autologous ones. Our impression seems to correlate well with the meta-analysis of Hammond et al . According to this meta-analysis commercial sealants have been shown to bond more consistently -by up to 10 times stronger than autologous when compared in vitro-, take less time to prepare and do not require autologous blood transfusion. This was the reason why commercial fibrin glue was employed for plugging the anal fistula in the present case.
Tips and tricks
We believe that in the present case we had a successful closure of the fistula due to tips and tricks that we have extracted from our experience both in simple anal fistulas and fibrin glue application. Patients' history and old hospitalizations have to be considered carefully in order to determine, if possible, the aetiology of the fistula and the predisposing factor. The visualization of fistulas' canal is of prime importance before any intervention -either surgical or not-. The preoperative evaluation includes colonoscopy, fistulography and MRI of the pelvis. In that way, the tract of the fistula is known before any intervention. Once the fistula is a "complex" one, then adequate treatment is applied after considering the general condition of the patient. In case of fibrin glue application, we perform no pre-operative bowel preparation. This strategy is in the same context as for all colonic operations in our department: intact colonic flora offers better healing . Immediately, before the fibrin glue application we like to perform a new fistulography. Once the fistula tract is visualized we perform blunt curettage. Mechanical curettage stops when blood exits the external orifice of the fistula. After that, chemical cleansing with hydrogen peroxide follows aiming both in introducing oxygen radicals in the fistula (bactericide) and in achieving haemostasis. Following that, catheterization of the fistula tract is achieved with a catheter that has a slightly smaller in diameter than the fistula. A small quantity of radioopaque material is introduced into the catheter in order to assure that its tip is placed in proximity to the internal orifice. The fibrin glue is then prepared by an assistant and a plastic double-lumen Y-connector joins the two syringes. The connector is connected to the catheter introduced in the fistula and secured. Coordination is primordial in the last phase of application since with one hand we should push the glue through the syringe into the fistula, while with the other we slowly retract the catheter tip through the fistula. To our opinion this is the most important phase since it is the only one requiring familiarization with the material. Failure to coordinate the two movements will lead to misplacement of the glue and failure of the procedure. A large drop of glue should be reserved to seal the external orifice of the fistula. Antibiotics and immobilization of the patient -in our opinion- offer nothing as post-interventional measures.
The best treatment for a disease is the one that gives at least the same result with the others with minimised risk for the life of the patient and minimal application effort. Conservative closure of fistula with fibrin tissue sealant is simple and especially in recurrent and difficult cases. Although anal fistula surgery is associated with considerable morbidity, mainly related to anal incontinence, our patient was successfully treated with the minimally invasive method by using fibrin glue, without endangering his life despite his precarious medical state. Despite the fact that not everybody believes in the effectiveness of fibrin glue application on anal fistulas, we suggest considering this solution in cases of complex fistulas at least as primary procedure in special populations such as the immunosupressed.
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Gonzalez-Ruiz C, Heartfield W, Briggs B, Vukasin P, Beart RW: Anorectal pathology in HIV/AIDS-infected patients has not been impacted by highly active antiretroviral therapy. Dis Colon Rectum. 2004, 47: 1483-1486.View ArticlePubMedGoogle Scholar
- Geminiano-Martínez EE, Ruíz-Esparza JP, Villanueva-Sáenz E, Alvarez-Tostado Fernández JF, Parrado-Montaño J: [Anorectal surgery in patients infected with human immunodeficiency virus]. Rev Gastroenterol Mex. 2000, 65: 152-158.PubMedGoogle Scholar
- Muñoz-Villasmil J, Sands L, Hellinger M: Management of perianal sepsis in immunosuppressed patients. Am Surg. 2001, 67: 484-486.PubMedGoogle Scholar
- Malik AI, Nelson RL: Surgical management of anal fistulae: a systematic review. Colorectal Dis. 2008, 10: 420-430. 10.1111/j.1463-1318.2008.01483.x.View ArticlePubMedGoogle Scholar
- Deeba S, Aziz O, Sains PS, Darzi A: Fistula-in-ano: advances in treatment. Am J Surg. 2008, 196: 95-99. 10.1016/j.amjsurg.2007.12.047.View ArticlePubMedGoogle Scholar
- Heitland W: [Fistulas and fissures. Part I: perianal fistulas]. Chirurg. 2008, 79: 430-438. 10.1007/s00104-008-1487-9.View ArticlePubMedGoogle Scholar
- Dunn CJ, Goa KL: Fibrin sealant: a review of its use in surgery and endoscopy. Drugs. 1999, 58: 863-886. 10.2165/00003495-199958050-00010.View ArticlePubMedGoogle Scholar
- Papavramidis TS, Kotzampassi K, Kotidis E, Eleftheriadis EE, Papavramidis ST: Endoscopic fibrin sealing of gastrocutaneous fistulas after sleeve gastrectomy and biliopancreatic diversion with duodenal switch. J Gastroenterol Hepatol. 2008, 23: 1802-1805. 10.1111/j.1440-1746.2008.05545.x.View ArticlePubMedGoogle Scholar
- Papavramidis ST, Eleftheriadis EE, Papavramidis TS, Kotzampassis KE, Gamvros OG: Endoscopic management of gastrocutaneous fistulas after bariatric surgery by using a fibrin sealant. Gastrointest Endosc. 2004, 59: 296-300. 10.1016/S0016-5107(03)02545-8.View ArticlePubMedGoogle Scholar
- Hammond TM, Grahn MF, Lunniss PJ: Fibrin glue in the management of anal fistulae. Colorectal Dis. 2004, 6: 308-319. 10.1111/j.1463-1318.2004.00676.x.View ArticlePubMedGoogle Scholar
- Loungnarath R, Dietz DW, Mutch MG, Birnbaum EH, Kodner IJ, Fleshman JW: Fibrin glue treatment of complex anal fistulas has low success rate. Dis Colon Rectum. 2004, 47: 432-436. 10.1007/s10350-003-0076-8.View ArticlePubMedGoogle Scholar
- Manookian CM, Sokol TP, Headrick C, Fleshner PR: Does HIV status influence the anatomy of anal fistulas?. Dis Colon Rectum. 1998, 41: 1529-1533. 10.1007/BF02237301.View ArticlePubMedGoogle Scholar
- Johnson EK, Gaw JU, Armstrong DN: Efficacy of anal fistula plug vs fibrin glue in closure of anorectal fistulas. Dis Colon Rectum. 2006, 49: 371-376. 10.1007/s10350-005-0288-1.View ArticlePubMedGoogle Scholar
- Ellis CN: Bioprosthetic Plugs for Complex Anal Fistulas: An Early Experience. J Surg Education. 2007, 64: 36-40. 10.1016/j.cursur.2006.07.005.View ArticleGoogle Scholar
- Swinscoe MT, Ventakasubramaniam AK, Jayne DG: Fibrin glue for fistula-in-ano: the evidence reviewed. Tech Coloproctol. 2005, 9: 89-94. 10.1007/s10151-005-0204-7.View ArticlePubMedGoogle Scholar
- Guenaga KK, Matos D, Wille-Jørgensen P: Mechanical bowel preparation for elective colorectal surgery. Cochrane Database Syst Rev. 2009, 21: CD001544-Google Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-230X/10/18/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.